Skip to main content
OpenTrials

Clinical trial condition

Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type

Explore clinical trials studying Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type trial results

Recruiting

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

NCT06834373

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +39 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
  • Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States
View Trial Details
Active, Not Recruiting

Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT02443077

Conditions
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 281 locations
View Trial Details

Related conditions